US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quantum Cyber

0.5465

-0.0608-10.01%

Pre-market: 0.4821-0.0644-11.78%04:26 EDT

Volume:7.42M

Turnover:4.25M

Market Cap:6.84M

PE:-0.20

High:0.6303

Open:0.6010

Low:0.5104

Close:0.6073

52wk High:4.43

52wk Low:0.4000

Shares:12.52M

Float Shares:10.85M

Volume Ratio:10.54

T/O Rate:68.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.7032

EPS(LYR):-22.3610

ROE:-488.32%

ROA:-89.61%

PB:10.66

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Quantum Cyber Divests ColoAlert IP, Refocuses on Pancreatic Screening

Mainz Biomed agrees to sell next-gen colorectal screening IP for $1.25 million

Mainz Biomed NV expected to post a loss of $2.80 a share - Earnings Preview

Mainz Biomed NV expected to post a loss of $2.80 a share - Earnings Preview

Mainz Biomed falls below Nasdaq $1.00 minimum bid price; compliance period runs through September 16, 2026

Mainz Biomed targets quantum and cyber defense acquisitions as it aligns strategy with Trump cybersecurity framework

Quantum Cyber announces stock ticker symbol change

BUZZ-Mainz Biomed to rebrand as Quantum Cyber, shares rise

Mainz Biomed Rebrands as Quantum Cyber, Reshapes Leadership

Mainz Biomed Nv - Plans Name Change to Quantum Cyber and Ticker Change to Qucy on March 12, 2026

THOMSON REUTERS

Press Release: Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/QUCY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"QUCY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QUCY\",,,,,undefined,":{"symbol":"QUCY","market":"US","secType":"STK","nameCN":"Quantum Cyber","latestPrice":0.5465,"timestamp":1776283200000,"preClose":0.6073,"halted":0,"volume":7422794,"hourTrading":{"tag":"盘前","latestPrice":0.4821,"preClose":0.5465,"latestTime":"04:26 EDT","volume":11519,"amount":5550.548565319999,"timestamp":1776327979891,"change":-0.0644,"changeRate":-0.117841,"amplitude":0.054346},"delay":0,"changeRate":-0.10011526428453807,"floatShares":10848000,"shares":12515300,"eps":-2.703188,"marketStatus":"Pre-Mkt","change":-0.0608,"latestTime":"04-16 04:28:00 EDT","open":0.601,"high":0.6303,"low":0.510401,"amount":4250486.54428662,"amplitude":0.19743,"askPrice":0.5609,"askSize":100,"bidPrice":0.445,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-2.703188,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776346200000},"marketStatusCode":1,"adr":0,"listingDate":1635998400000,"exchange":"NASDAQ","adjPreClose":0.5465,"preHourTrading":{"tag":"盘前","latestPrice":0.4821,"preClose":0.5465,"latestTime":"04:26 EDT","volume":11519,"amount":5550.548565319999,"timestamp":1776327979891,"change":-0.0644,"changeRate":-0.117841,"amplitude":0.054346},"postHourTrading":{"tag":"盘后","latestPrice":0.5399,"preClose":0.5465,"latestTime":"19:59 EDT","volume":6915203,"amount":4573071.781844,"timestamp":1776297562196,"change":-0.0066,"changeRate":-0.012077,"amplitude":0.661482},"volumeRatio":10.535803707727574},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QUCY\",,,,,undefined,":{"symbol":"QUCY","floatShares":10848000,"roa":"-89.61%","roe":"-488.32%","lyrEps":-22.360981,"volumeRatio":10.535803707727574,"shares":12515300,"dividePrice":0,"high":0.6303,"amplitude":0.19743,"preClose":0.6073,"low":0.510401,"week52Low":0.4,"pbRate":"10.66","psRate":"12.73","week52High":4.4299,"institutionHeld":0,"latestPrice":0.5465,"eps":-2.703188,"divideRate":0,"volume":7422794,"delay":0,"ttmEps":-2.703188,"open":0.601,"prevYearClose":1.12,"prevWeekClose":0.443,"prevMonthClose":0.4738,"prevQuarterClose":0.4738,"fiveDayClose":0.51,"twentyDayClose":0.5689,"sixtyDayClose":1.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QUCY\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"QUCY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774987200000,"name":null,"time":"Post Market","dateTimestamp":1774929600000,"actualEps":null},{"date":"2025-09-26","symbol":"QUCY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1758916800000,"name":null,"time":"Post Market","dateTimestamp":1758859200000,"actualEps":null},{"date":"2025-09-08","symbol":"QUCY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1757318400000,"name":null,"time":"Pre-Market","dateTimestamp":1757304000000,"actualEps":null},{"date":"2025-04-01","symbol":"QUCY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743494400000,"name":null,"time":"Pre-Market","dateTimestamp":1743480000000,"actualEps":null},{"market":"US","date":"2024-12-03","symbol":"QUCY","defaultRemindTime":1733236200000,"type":"split","dateTimestamp":1733202000000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QUCY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QUCY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1772856000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QUCY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QUCY","date":"2026-04-14","current":-0.202169,"percent":0.238095,"low":-0.486466,"twenty":-0.393092,"median":-0.35981,"eighty":-0.315048,"high":-0.274635,"avg":-0.361213,"sd":0.051574,"marketCap":6330256},"quantilePoints":[{"date":"2026-03-13","current":-0.43156,"twenty":-0.43156,"median":-0.43156,"eighty":-0.43156,"marketCap":8187182},{"date":"2026-03-20","current":-0.387841,"twenty":-0.456318,"median":-0.415143,"eighty":-0.387841,"marketCap":7357766},{"date":"2026-03-27","current":-0.309534,"twenty":-0.43156,"median":-0.375306,"eighty":-0.328863,"marketCap":5872195},{"date":"2026-04-02","current":-0.314679,"twenty":-0.405293,"median":-0.329391,"eighty":-0.311961,"marketCap":5969815},{"date":"2026-04-10","current":-0.365947,"twenty":-0.394738,"median":-0.35981,"eighty":-0.314257,"marketCap":5932269},{"date":"2026-04-14","current":-0.390498,"twenty":-0.393092,"median":-0.35981,"eighty":-0.315048,"marketCap":6330256}],"updateTime":1776328080529},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QUCY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627532592","title":"Quantum Cyber Divests ColoAlert IP, Refocuses on Pancreatic Screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2627532592","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627532592?lang=en_us&edition=fundamental","pubTime":"2026-04-16 05:50","pubTimestamp":1776289808,"startTime":"0","endTime":"0","summary":"Quantum Cyber ( ($QUCY) ) just unveiled an update. In February 2026, Quantum Cyber’s board decided to wind down its ColoAlert colorectal cancer scr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quantum-cyber-divests-coloalert-ip-refocuses-on-pancreatic-screening?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quantum-cyber-divests-coloalert-ip-refocuses-on-pancreatic-screening?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","LU1169589451.USD","LU1487256676.USD","QUCY","LU1169590202.USD","BK4588","BK4136","IP","LU2463526074.USD","LU1481600234.SGD","LU1481599808.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627258918","title":"Mainz Biomed agrees to sell next-gen colorectal screening IP for $1.25 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627258918","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627258918?lang=en_us&edition=fundamental","pubTime":"2026-04-16 05:01","pubTimestamp":1776286866,"startTime":"0","endTime":"0","summary":"Mainz Biomed entered an asset purchase agreement on April 9, 2026 to sell intellectual property for its next-generation colorectal cancer screening candidates to a buyer incorporated in Italy for USD 1.25 million.Closing is expected by April 23, 2026, with an option to extend deadline by seven days.Proceeds are slated for settlement of outstanding liabilities, with remainder for general corporate purposes.Transaction follows March 28, 2026 sale of intellectual property behind ColoAlert.Mainz Biomed will continue development of its pancreatic cancer screening product.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mainz Biomed NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, An","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL5Mczjy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QUCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624537802","title":"Mainz Biomed NV  expected to post a loss of $2.80 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2624537802","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624537802?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:02","pubTimestamp":1774987328,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV  expected to post a loss of $2.80 a share - Earnings Preview Mainz Biomed NV QUCY.OQ, QUCY.O is expected to  report resultson April 2 (estimated) for the period ending March 31 2025The","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL8N40J2D0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QUCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622803383","title":"Mainz Biomed NV  expected to post a loss of $2.80 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2622803383","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622803383?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:47","pubTimestamp":1774644440,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV  expected to post a loss of $2.80 a share - Earnings Preview Mainz Biomed NV QUCY.OQ, QUCY.O is expected to  report resultson April 2 (estimated) for the period ending March 31 2025The","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL8N40F22P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QUCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622653002","title":"Mainz Biomed falls below Nasdaq $1.00 minimum bid price; compliance period runs through September 16, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622653002","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622653002?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:31","pubTimestamp":1774470713,"startTime":"0","endTime":"0","summary":"Mainz Biomed received a Nasdaq notice that it failed to meet the USD 1.00 minimum bid price requirement after 30 consecutive business days below the threshold.The company has until September 16, 2026 to regain compliance by maintaining a closing bid price of at least USD 1.00 for 10 consecutive business days.Nasdaq said the ordinary shares will remain listed during the compliance period, subject to meeting other listing requirements.If compliance is not regained by the deadline, the shares could become subject to delisting, with a potential additional 180-day cure period if eligibility conditions are met.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mainz Biomed NV published the original content used to generate this news brief via E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL7fLYD1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QUCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620422862","title":"Mainz Biomed targets quantum and cyber defense acquisitions as it aligns strategy with Trump cybersecurity framework","url":"https://stock-news.laohu8.com/highlight/detail?id=2620422862","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620422862?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:31","pubTimestamp":1773750712,"startTime":"0","endTime":"0","summary":"Quantum Cyber said it is aligning its strategy with the Trump administration’s National Cybersecurity Strategy, with a focus on quantum computing and cyber defense priorities. The company said it is evaluating acquisition candidates in quantum computing, post-quantum cryptography, and zero-trust network architecture. Quantum Cyber also said it is conducting preliminary due diligence and holding discussions with potential acquisition targets. Separately, shareholder David Lazar pre-funded a second tranche of USD 3 million under a private placement, bringing total funding received under the commitment to USD 6 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mainz Biomed NV published the original content used to generate this news","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL9BsKjc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QUCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619191185","title":"Quantum Cyber announces stock ticker symbol change","url":"https://stock-news.laohu8.com/highlight/detail?id=2619191185","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619191185?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:35","pubTimestamp":1773401758,"startTime":"0","endTime":"0","summary":"Mainz Biomed (MYNZ), doing business as Quantum Cyber (QUCY), announced, effective upon the commencement of trading on March 12, it officially chang...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quantum-cyber-announces-stock-ticker-symbol-change-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quantum-cyber-announces-stock-ticker-symbol-change-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QUCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618942312","title":"BUZZ-Mainz Biomed to rebrand as Quantum Cyber, shares rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2618942312","media":"Reuters","labels":["executive","shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618942312?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:13","pubTimestamp":1773231232,"startTime":"0","endTime":"0","summary":"BUZZ-Mainz Biomed to rebrand as Quantum Cyber, shares rise** U.S.-listed shares of cancer-focused diagnostic company Mainz Biomed 4TO.F, MYNZ.O jump 28% to $1.07 premarket** Co to change its name to Quantum Cyber and says its U.S.-listed shares will trade under new ticker QUCY from March 12, pending shareholder approval** Names former U.S. Homeland Security official Robert Liscouski as chairman** Adds that it will keep developing pancreatic cancer screening business in the U.S. and is considering selling its colorectal cancer screening assets** Says it is winding down its German subsidiary and cautions that the plans face regulatory and development risks** Shares down 26% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL4N3ZZ14P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","QUCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618194429","title":"Mainz Biomed Rebrands as Quantum Cyber, Reshapes Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2618194429","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618194429?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:59","pubTimestamp":1773230397,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. ( ($MYNZ) ) has issued an update. On March 11, 2026, Mainz Biomed appointed cybersecurity and quantum computing veteran Robert P....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-rebrands-as-quantum-cyber-reshapes-leadership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-rebrands-as-quantum-cyber-reshapes-leadership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QUCY","MYNZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618941910","title":"Mainz Biomed Nv - Plans Name Change to Quantum Cyber and Ticker Change to Qucy on March 12, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618941910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618941910?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:30","pubTimestamp":1773228601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nTUA3KXWHW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4023","BK4602","QUBX","BK4608","BK4170","BK4591","MYNZ","QUCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618941171","title":"Press Release: Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2618941171","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618941171?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:30","pubTimestamp":1773228600,"startTime":"0","endTime":"0","summary":"BERKELEY, Calif., March 11, 2026  -- Mainz Biomed N.V. , a molecular genetics diagnostic company specializing in the early detection of cancer, today announced that Robert P. Liscouski has been appointed Chairman of its Board of Directors. Further, the Company announced that it plans to change its name to Quantum Cyber and change its Nasdaq ticker symbol to QUCY, beginning on March 12, 2026. The permanent election of Mr. Liscouski and the change of Company name will become effective at the Company's extraordinary general meeting, being planned for April 2026. The Company will begin doing business as Quantum Cyber and trading under the symbol QUCY beginning on March 12, 2026.Mr. Liscouski is a frequent contributor to CNBC, CNN, BBC, Fox News, and other business and security media on Homeland Security, Terrorism and Cyber Security issues and has appeared before Congress on Homeland Security Issues. Mr. Liscouski received his Master of Public Administration from the John F. Kennedy School","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","QUCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}